WEAVER GREGORY L
Insider CIK 1251779 · SVON Chief Financial Officer · ALT Chief Financial Officer · ATOS Former EVP, CFO, & Director, Director · EGLT Director · ATAI Chief Financial Officer · FCSC Chief Financial Officer · CLSN SVP & Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALT Altimmune, Inc. | M Exercise deriv | 2026-10-01 | 2026-10-05 | 14,475 | — | $0 | 43,425 | SEC↗ |
| ALT Altimmune, Inc. | F Tax w/h | 2026-10-01 | 2026-10-05 | 4,379 | $2.76 | $12.1K | 49,927 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise | 2026-10-01 | 2026-10-05 | 14,475 | — | $0 | 54,306 | SEC↗ |
| ALT Altimmune, Inc. | A Award | 2026-07-31 | 2026-08-03 | 1,753 | $2.41 | $4.2K | 39,831 | SEC↗ |
| ALT Altimmune, Inc. | A Award | 2026-07-31 | 2026-08-03 | 1,753 | $2.41 | $4.2K | 39,831 | SEC↗ |
| ALT Altimmune, Inc. | P Buy | 2026-04-01 | 2026-04-01 | 10,000 | $3.15 | $31.5K | 38,078 | SEC↗ |
| ALT Altimmune, Inc. | P Buy | 2026-03-06 | 2026-03-09 | 5,000 | $3.54 | $17.7K | 28,078 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2026-02-26 | 2026-02-27 | 111,000 | — | $0 | 111,000 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2026-02-26 | 2026-02-27 | 259,000 | — | $0 | 259,000 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise deriv | 2025-11-11 | 2025-11-12 | 18,750 | — | $0 | 56,250 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise | 2025-11-11 | 2025-11-12 | 18,750 | — | $0 | 28,750 | SEC↗ |
| ALT Altimmune, Inc. | F Tax w/h | 2025-11-11 | 2025-11-12 | 5,672 | $4.28 | $24.3K | 23,078 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2025-10-01 | 2025-10-03 | 166,800 | — | $0 | 166,800 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2025-10-01 | 2025-10-03 | 57,900 | — | $0 | 57,900 | SEC↗ |
| ALT Altimmune, Inc. | P Buy | 2025-03-13 | 2025-03-14 | 10,000 | $5.20 | $52.0K | 10,000 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2024-11-11 | 2024-11-12 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2024-11-11 | 2024-11-12 | 225,000 | — | $0 | 225,000 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | S Sale | 2023-11-15 | 2023-11-17 | 50,000 | $0.65 | $32.5K | 55 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | P Buy | 2023-06-20 | 2023-06-20 | 50,000 | $0.97 | $48.5K | 50,055 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award deriv | 2023-06-01 | 2023-06-05 | 2,600,000 | — | $0 | 2,600,000 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award deriv | 2023-05-04 | 2023-05-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award deriv | 2022-05-13 | 2022-05-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATAI ATAI Life Sciences N.V. | A Award deriv | 2022-03-02 | 2022-03-04 | 228,000 | — | $0 | 228,000 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | M Exercise deriv | 2021-07-02 | 2021-07-07 | 4,581 | — | $0 | 0 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | M Exercise deriv | 2021-07-02 | 2021-07-07 | 45,000 | — | $0 | 0 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | M Exercise deriv | 2021-07-02 | 2021-07-07 | 70,000 | — | $0 | 0 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | M Exercise deriv | 2021-07-02 | 2021-07-07 | 45,000 | — | $0 | 0 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | F Tax w/h | 2021-07-02 | 2021-07-07 | 57,084 | $6.40 | $365.3K | 107,497 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | M Exercise | 2021-07-02 | 2021-07-07 | 70,000 | $1.70 | $119.0K | 164,581 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | S Sale | 2021-07-02 | 2021-07-07 | 107,497 | $5.58 | $599.8K | 0 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | M Exercise | 2021-07-02 | 2021-07-07 | 45,000 | $2.52 | $113.4K | 94,581 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | M Exercise | 2021-07-02 | 2021-07-07 | 4,581 | $5.64 | $25.8K | 4,581 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | M Exercise | 2021-07-02 | 2021-07-07 | 45,000 | $2.38 | $107.1K | 49,581 | SEC↗ |
| ATAI ATAI Life Sciences N.V. | P Buy | 2021-06-22 | 2021-06-24 | 4,666 | $15.00 | $70.0K | 4,666 | SEC↗ |
| ATAI ATAI Life Sciences N.V. | A Award deriv | 2021-06-17 | 2021-06-22 | 67,726 | — | $0 | 67,726 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award deriv | 2021-05-14 | 2021-05-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATOS ATOSSA THERAPEUTICS, INC. | A Award deriv | 2020-05-15 | 2020-05-19 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2020-03-15 | 2020-03-16 | 3,750 | — | $0 | 0 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise | 2020-03-15 | 2020-03-16 | 3,750 | — | $0 | 11,517 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | F Tax w/h | 2020-03-15 | 2020-03-16 | 1,086 | $2.85 | $3.1K | 10,431 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2020-01-30 | 2020-01-31 | 5,000 | — | $0 | 15,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise deriv | 2020-01-30 | 2020-03-04 | 5,000 | — | $0 | 15,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | F Tax w/h | 2020-01-30 | 2020-01-31 | 1,733 | $3.91 | $6.8K | 7,767 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise | 2020-01-30 | 2020-01-31 | 5,000 | — | $0 | 9,500 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | M Exercise | 2020-01-30 | 2020-03-04 | 5,000 | — | $0 | 9,500 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | F Tax w/h | 2020-01-30 | 2020-03-04 | 1,733 | $3.91 | $6.8K | 7,767 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2019-05-17 | 2019-05-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| EGLT Egalet Corp | D To issuer deriv | 2019-01-31 | 2019-02-04 | 10,000 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | D To issuer deriv | 2019-01-31 | 2019-02-04 | 667 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | D To issuer deriv | 2019-01-31 | 2019-02-04 | 2,083 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | D To issuer deriv | 2019-01-31 | 2019-02-04 | 20,000 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | D To issuer deriv | 2019-01-31 | 2019-02-04 | 75,000 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | D To issuer deriv | 2019-01-31 | 2019-02-04 | 58,133 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | D To issuer deriv | 2019-01-31 | 2019-02-04 | 29,666 | — | $0 | 0 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2019-01-30 | 2019-01-31 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2019-01-30 | 2019-01-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2018-06-27 | 2018-06-29 | 45,000 | — | $0 | 45,000 | SEC↗ |
| EGLT Egalet Corp | A Award deriv | 2018-05-14 | 2018-05-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | P Buy | 2018-03-23 | 2018-03-26 | 4,500 | $8.56 | $38.5K | 4,500 | SEC↗ |
| ELOX Eloxx Pharmaceuticals, Inc | A Award deriv | 2017-12-20 | 2018-02-23 | 399,266 | — | $0 | 399,266 | SEC↗ |
| SVON Eloxx Pharmaceuticals, Inc | A Award deriv | 2017-12-20 | 2017-12-22 | 399,266 | — | $0 | 399,266 | SEC↗ |
| EGLT Egalet Corp | A Award deriv | 2017-06-08 | 2017-06-12 | 58,133 | — | $0 | 58,133 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2017-05-24 | 2017-05-26 | 54,949 | — | $0 | 69,917 | SEC↗ |
| EGLT Egalet Corp | A Award deriv | 2016-06-15 | 2016-06-17 | 29,666 | $4.98 | $147.7K | 29,666 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2016-05-18 | 2016-05-19 | 112,190 | — | $0 | 112,190 | SEC↗ |
| EGLT Egalet Corp | A Award deriv | 2015-06-10 | 2016-06-17 | 10,000 | $12.08 | $120.8K | 10,000 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2015-05-12 | 2015-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EGLT Egalet Corp | A Award deriv | 2014-09-30 | 2014-10-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EGLT Egalet Corp | A Award deriv | 2014-06-09 | 2014-06-11 | 667 | — | $0 | 667 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2014-05-06 | 2014-05-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ATOS ATOSSA GENETICS INC | D To issuer | 2014-05-06 | 2014-05-08 | 24,510 | — | $0 | 0 | SEC↗ |
| EGLT Egalet Corp | A Award deriv | 2014-02-05 | 2014-02-07 | 2,083 | — | $0 | 2,083 | SEC↗ |
| FCSC Fibrocell Science, Inc. | A Award deriv | 2014-01-17 | 2014-01-21 | 40,000 | — | $0 | 165,000 | SEC↗ |
| ATOS ATOSSA GENETICS INC | P Buy | 2013-11-21 | 2013-11-22 | 10,000 | $2.58 | $25.8K | 34,510 | SEC↗ |
| FCSC Fibrocell Science, Inc. | P Buy | 2013-11-20 | 2013-11-20 | 10,000 | $3.51 | $35.1K | 10,000 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award deriv | 2013-10-10 | 2013-10-15 | 57,190 | — | $0 | 57,190 | SEC↗ |
| ATOS ATOSSA GENETICS INC | A Award | 2013-10-10 | 2013-10-15 | 24,510 | — | $0 | 24,510 | SEC↗ |
| FCSC Fibrocell Science, Inc. | A Award deriv | 2013-08-26 | 2013-08-28 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CLSN Celsion CORP | S Sale | 2013-03-19 | 2013-03-21 | 37,272 | $1.06 | $39.5K | 0 | SEC↗ |
| CLSN Celsion CORP | X Exercise deriv | 2012-12-18 | 2012-12-19 | 8,636 | $2.77 | $23.9K | 0 | SEC↗ |
| CLSN Celsion CORP | M Exercise | 2012-12-18 | 2012-12-19 | 8,636 | $2.77 | $23.9K | 37,272 | SEC↗ |
| CLSN Celsion CORP | A Award deriv | 2012-06-15 | 2012-06-18 | 36,250 | $2.15 | $77.9K | 282,009 | SEC↗ |
| CLSN Celsion CORP | A Award deriv | 2012-02-27 | 2012-02-28 | 13,750 | — | $0 | 245,759 | SEC↗ |